BSECompany Update3d ago · 7 Nov 2026, 11:05 am

Audio link for the conference call

Cohance Lifesciences Ltd · 543064

✦ AI SummaryResults

Cohance Lifesciences Ltd has uploaded the audio recording of its conference call for the quarter and half year ended 30 September 2026 on its website.

Analysis Scores

Earnings Impact5/10

Growth Catalyst3/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk2/10

Liquidity Impact8/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Attachments (1)

📄

07d74d2d-57e1-46e4-b4ce-a4149f581008.pdf

pdf

Download →

View document text

7 November 2026, To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Audio recording of the conference call for the quarter and half year ended 30 September 2026 With reference to our results conference call intimation dated 3 November 2026, that audio recording of the conference call for the quarter and half year ended 30 September 2026 held on Friday, 6 November 2026, has been uploaded on the Company's website and available at the below link: https://www.cohance.com/wp-content/uploads/2026/11/10047946.mp3 Kindly take the same on record. Thanking you. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir. K Mishra Company Secretary & Compliance Officer